×
About 403 results

ALLMedicine™ Sezary Syndrome Center

Research & Reviews  199 results

CCR4 in cutaneous T-cell lymphoma: therapeutic targeting of a pathogenic driver.
https://doi.org/10.1002/eji.202049043
European Journal of Immunology; Nicolay JP, Albrecht JD et. al.

Apr 3rd, 2021 - New treatments are needed for patients with cutaneous T cell lymphoma (CTCL), particularly for advanced mycosis fungoides (MF) and Sezary syndrome (SS). The immunopathology of MF and SS is complex, but recent advances in tumor microenvironment und...

The importance of palpation in the skin cancer screening examination.
https://doi.org/10.1111/jocd.14054
Journal of Cosmetic Dermatology; Gorman BG, Hanson J et. al.

Mar 22nd, 2021 - With the recent unprecedented shift towards contactless healthcare solutions, providers should recall the value that proper palpation adds to dermatologic practice. We present a case that demonstrates the limitations of touchless care and how prop...

IFN-γ reshapes monocyte responsiveness in Sezary syndrome.
https://doi.org/10.1111/ijd.15251
International Journal of Dermatology References; Torrealba MP, Manfrere KCG et. al.

Oct 27th, 2020 - IFN-γ reshapes monocyte responsiveness in Sezary syndrome.|2020|Torrealba MP,Manfrere KCG,Yoshikawa FSY,Pereira NZ,Branco ACCC,|

Histopathologic Characterization of Mogamulizumab-associated Rash.
https://doi.org/10.1097/PAS.0000000000001587
The American Journal of Surgical Pathology; Wang JY, Hirotsu KE et. al.

Sep 25th, 2020 - Rash is one of the most common adverse events observed with mogamulizumab, an anti-C-C chemokine receptor 4 monoclonal antibody approved for previously treated mycosis fungoides (MF) and Sezary syndrome (SS). Given the nonspecific clinical present...

Mapping signal transducer and activator of transcription (STAT) activity in different s...
https://doi.org/10.1111/ijd.15036
International Journal of Dermatology References; Olszewska B, Żawrocki A et. al.

Jul 9th, 2020 - Deregulation of signal transducer and activator of transcription (STAT) signaling is known to participate in the pathogenesis of cutaneous T-cell lymphomas (CTCLs). However, published results regarding STAT expression in different stages of CTCLs ...

see more →

Clinicaltrials.gov  203 results

CCR4 in cutaneous T-cell lymphoma: therapeutic targeting of a pathogenic driver.
https://doi.org/10.1002/eji.202049043
European Journal of Immunology; Nicolay JP, Albrecht JD et. al.

Apr 3rd, 2021 - New treatments are needed for patients with cutaneous T cell lymphoma (CTCL), particularly for advanced mycosis fungoides (MF) and Sezary syndrome (SS). The immunopathology of MF and SS is complex, but recent advances in tumor microenvironment und...

The importance of palpation in the skin cancer screening examination.
https://doi.org/10.1111/jocd.14054
Journal of Cosmetic Dermatology; Gorman BG, Hanson J et. al.

Mar 22nd, 2021 - With the recent unprecedented shift towards contactless healthcare solutions, providers should recall the value that proper palpation adds to dermatologic practice. We present a case that demonstrates the limitations of touchless care and how prop...

IFN-γ reshapes monocyte responsiveness in Sezary syndrome.
https://doi.org/10.1111/ijd.15251
International Journal of Dermatology References; Torrealba MP, Manfrere KCG et. al.

Oct 27th, 2020 - IFN-γ reshapes monocyte responsiveness in Sezary syndrome.|2020|Torrealba MP,Manfrere KCG,Yoshikawa FSY,Pereira NZ,Branco ACCC,|

Histopathologic Characterization of Mogamulizumab-associated Rash.
https://doi.org/10.1097/PAS.0000000000001587
The American Journal of Surgical Pathology; Wang JY, Hirotsu KE et. al.

Sep 25th, 2020 - Rash is one of the most common adverse events observed with mogamulizumab, an anti-C-C chemokine receptor 4 monoclonal antibody approved for previously treated mycosis fungoides (MF) and Sezary syndrome (SS). Given the nonspecific clinical present...

Mapping signal transducer and activator of transcription (STAT) activity in different s...
https://doi.org/10.1111/ijd.15036
International Journal of Dermatology References; Olszewska B, Żawrocki A et. al.

Jul 9th, 2020 - Deregulation of signal transducer and activator of transcription (STAT) signaling is known to participate in the pathogenesis of cutaneous T-cell lymphomas (CTCLs). However, published results regarding STAT expression in different stages of CTCLs ...

see more →

Patient Education  1 results see all →